Q32 Bio
QTTB
120 hedge funds and large institutions have $123M invested in Q32 Bio in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 30 reducing their positions, and 18 closing their positions.
115% more call options, than puts
Call options by funds: $793K | Put options by funds: $369K
37% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 30
11% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 18
1% more funds holding
Funds holding: 119 → 120 (+1)
0.17% more ownership
Funds ownership: 3.12% → 3.29% (+0.17%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
51% less capital invested
Capital invested by funds: $252M → $123M (-$129M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$5.21M |
| 2 |
Goldman Sachs
New York
|
+$2.16M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.01M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$950K |
| 5 |
Renaissance Technologies
New York
|
+$787K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$1.99M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$940K |
| 3 |
D.E. Shaw & Co
New York
|
-$871K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$778K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$713K |
QTTB Hedge Fund Activity: Q4 2021 in Review
120 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q4 2021, worth a combined $123M — down 51% from $252M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new QTTB positions and 18 closed out — a net gain of 2 holders — while 41 added to existing stakes and 30 trimmed.
The largest buyer was Woodline Partners, opening a new position worth an estimated $5.21M. The largest seller was JP Morgan Chase, cutting an estimated $1.99M.
- 120 institutional investors held Q32 Bio (QTTB) as of Q4 2021, up from 119 in Q3 2021.
- Funds reported $123M of Q32 Bio stock for Q4 2021, down 51% quarter-over-quarter.
- 20 funds opened new Q32 Bio positions in Q4 2021 and 18 closed out, a net change of +2 holders.
- The largest Q32 Bio buyer in Q4 2021 was Woodline Partners, an estimated $5.21M added.
- The largest Q32 Bio seller in Q4 2021 was JP Morgan Chase, an estimated $1.99M sold.
Based on aggregated 13F filings for Q4 2021.